Responsibility of the pharmaceutical industry

Sustainability and communication with publics

Bibliographic Data

ID12928270
AuthorsAna Ibáñez-Hernández (0000-0002-0023-4232, University of Alicante, corresponding author), Carmen Carreton-Ballester (0000-0002-4851-9683, University of Alicante), Natalia Papí Gálvez (0000-0002-4871-1691, University of Alicante)
Year2025
Volume17
Issue1
Pages61-87
Publication date2025-04-01
Peer ReviewedYes
Open AccessNo
TypeARTICLE
VenueCatalan Journal of Communication & Cultural Studies (JOURNAL)
Journal identifiersISSN: 1757-1898 • E-ISSN: 1757-1901
PublisherIntellect (PUBLISHER • GB)
DOI10.1386/cjcs_00104_1
OpenAlexW4410888041
LanguageEN
References cited19

Issues such as global health and universal accessibility to medicines and vaccines have become particularly important in the commitment of the pharmaceutical industry since the last health crisis. The 2030 Agenda has also marked a turning point in the industry, which has had to align its corporate strategies to achieve the Sustainable Development Goals (SDGs). This exploratory-descriptive study, with a mixed approach, presents an insight into the social responsibility of the pharmaceutical companies with the best reputation in Spain, in their relationship with their publics and their contribution to sustainable development, with the content analysis of their responsibility reports and the diffusion of responsible actions on the web. The results show that there are indicators, such as pharmacovigilance in the global dimension, or SDG 5 on gender equality and empowerment of all women and girls, that are barely addressed

Biology · Business · Pharmaceutical industry · Political science · Public relations · Publics · Sustainability · Corporate Social Responsibility Reporting · Ethics in Business and Education · Law · Medicine · Sustainability in Higher Education · Pharmacology

Tools

Open DOI